Browsing: Vaccines

As the year wraps up, travel excitement kicks in! Before jetting off, protect your health by getting essential travel vaccines. Schedule vaccinations 4–6 weeks before your trip for maximum immunity, and let’s explore the world safely!

Flu shots are now available at selected Guardian, Unity, and Watsons pharmacies in Singapore in a new MOH trial to increase vaccination rates. Open to individuals 18 and above, these community locations aim to make flu vaccines more accessible for seniors and those at risk, supporting Singapore’s preventive care goals.

Health advocates are urging the Department of Health (DOH) to expedite flu vaccine distribution due to a surge in influenza cases and the emergence of mpox. Experts warn that vulnerable populations, particularly the elderly, face increased risks as the rainy season exacerbates virus transmission

The United Nations has expressed serious concerns over the stagnation of childhood immunisation levels worldwide.  Recent data indicates that vaccination rates have stalled, raising alarms about potential outbreaks of preventable diseases.

Faith Villanueva, Co-Chair of the Adult Immunization Committee for Microbiology and Infectious Diseases (PSMID) Inc., emphasised the importance of incorporating…

The Indonesian Society of Internal Medicine (PAPDI) has unveiled a significant update to its adult vaccination recommendations for 2024, marking a major stride towards fortifying public health in Indonesia and across Asia.

AstraZeneca has announced the global discontinuation of its COVID-19 vaccine, Vaxzevria, marking a significant turn in the pandemic’s vaccination strategy.

Discover how the Department of Health in the Philippines has reached a significant milestone by administering measles vaccinations to over 646,000 children nationwide.

Caloocan City Mayor Dale Gonzalo “Along” Malapitan, announced the launch of a free vaccination program to combat various strains of the human papillomavirus (HPV). 

The Duke-NUS research team, collaborating with Duke University and the National University of Singapore, conducted a preclinical comparison between nasal and subcutaneous administration of the COVID-19 vaccine. Their findings were published in eBioMedicine. It revealed that the intranasal route not only induces a strong mucosal antibody response but also enhances long-term mucosal and systemic immune protection.